DOI: https://doi.org/10.14710/jati.20.2.85-94

ANALISIS KETERLAMBATAN PROSES PENGADAAN OBAT KARDIOVASKULAR RUMAH SAKIT SWASTA DI JAKARTA

*Dana Nasihardani orcid  -  Universitas Katolik Indonesia Atma Jaya;, Indonesia
Ronald Sukwadi  -  Universitas Katolik Indonesia Atma Jaya, Indonesia
Trifenaus Prabu Hidayat  -  Universitas Katolik Indonesia Atma Jaya, Indonesia
Hendri Pujianto orcid  -  Akademi Komunitas Industri Tekstil dan Produk Tekstil;, Indonesia

Citation Format:
Abstract

Penyakit kardiovaskular merupakan penyebab utama kematian di dunia, termasuk Indonesia, dengan angka kematian mencapai 650.000 per tahun. Ketersediaan obat yang tepat waktu menjadi faktor krusial dalam penanganan penyakit ini. Namun, banyak rumah sakit di Jakarta mengalami keterlambatan dalam pengadaan obat Kardiovaskular. Penelitian ini bertujuan mengidentifikasi faktor-faktor yang menyebabkan keterlambatan tersebut, antara lain proses birokrasi yang kompleks, kurangnya koordinasi antar pihak terkait, dan keterbatasan stok dari distributor. Hasil penelitian di salah satu rumah sakit swasta di Jakarta menunjukkan bahwa kekosongan stok di distributor menjadi penyebab utama keterlambatan dengan persentase sebesar 35%. Selain itu, kesalahan dalam pemilihan cabang distributor dan pemesanan ganda juga berkontribusi. Keterlambatan ini berdampak negatif terhadap kualitas layanan kesehatan dan keselamatan pasien, karena ketersediaan obat yang tidak memadai dapat menurunkan efektivitas pengobatan. Untuk itu, direkomendasikan  usulan strategi pencegahan dalam penanganan keterlambatan pengadaan obat dengan pendekatan FMEA(Failure Mode and Effect Analysis) dari hasil diagram fishbone penyusunan strategi pencegahan didasarkan pada tingkat prioritas risiko, sehingga intervensi difokuskan pada faktor penyebab yang memiliki dampak paling signifikan dan tingkat kemungkinan kejadian yang tertinggi.


Abstract

[Analysis of Delay in Procurement Process of Cardiovascular Drug in Private Hospitals in Jakarta] Cardiovascular disease is the leading cause of death in the world, including Indonesia, with a death rate of 650,000 per year. The timely availability of drugs is a crucial factor in the treatment of this disease. However, many hospitals in Jakarta experience delays in procuring cardiovascular drugs. This study aims to identify factors that cause these delays, including complex bureaucratic processes, lack of coordination between related parties, and limited stock from distributors. The study conducted at a private hospital in Jakarta revealed that stock vacancies at distributors accounted for 35% of the delays. Furthermore, errors in the selection of distributor branches and double ordering also played a significant role in the delays. These delays have a negative impact on the quality of health services and patient safety, as inadequate drug availability can reduce the effectiveness of treatment. For this reason, it is recommended to propose a preventive strategy in handling delays in drug procurement using the FMEA (Failure Mode  and Effect Analysis) approach. From the results of the fishbone diagram, the preparation of preventive strategies is based on the level of risk priority, so that interventions are focused on the causal factors that have the most significant impact and the highest probability of occurrence.

Keywords: cardiovascular disease; drug procurement delays; distributor; healthcare quality; inventory management

Fulltext View|Download
Keywords: penyakit kardiovaskular; keterlambatan pengadaan obat; distributor; kualitas layanan kesehatan; manajemen inventaris

Article Metrics:

Article Info
Section: Case Studies
Language : ID
Recent articles
INFANT INCUBATOR DESIGN USING ERGONOMIC FUNCTION DEPLOYMENT (EFD) METHOD TO IMPROVE COMFORT AND EFFECTIVENESS OF NEONATAL CARE PENGENDALIAN PERSEDIAAN BAHAN BAKU MENGGUNAKAN METODE ANALISIS ABC, PERAMALAN, DAN ECONOMIC ORDER QUANTITY (EOQ) PADA PT. XYZ EVALUATING SERVICE QUALITY AND PASSENGER SATISFACTION OF FEEDER BUSES IN URBAN PUBLIC TRANSPORTATION PENINGKATAN KUALITAS DENGAN PENDEKATAN SIX SIGMA DAN PERPEKTIF MBNQA SEBAGAI KRITERIA PRASYARAT BAKU MUTU PADA PT. TAMANACO ANALISIS KETERLAMBATAN PROSES PENGADAAN OBAT KARDIOVASKULAR RUMAH SAKIT SWASTA DI JAKARTA More recent articles
Most cited articles
PENERAPAN FUZZY ANALYTIC HIERARCHY PROCESS DALAM METODE MULTI ATTRIBUTE FAILURE MODE ANALYSIS UNTUK MENGIDENTIFIKASI PENYEBAB KEGAGALAN POTENSIAL PADA PROSES PRODUKSI ANALISIS KEPUASAN PELANGGAN DENGAN IMPORTANCE PERFORMANCE ANALYSIS DI SBU LABORATORY CIBITUNG PT SUCOFINDO (PERSERO) PERANCANGAN ALAT PENYADAP KARET DI KABUPATEN LANGKAT SUMATERA UTARA DENGAN METODE QUALITY FUNCTION DEPLOYMENT (QFD) DAN MODEL KANO PENGARUH MOTIVASI KERJA DAN GAYA KEPEMIMPINAN TERHADAP DISIPLIN KERJA SERTA DAMPAKNYA PADA KINERJA KARYAWAN (STUDI KASUS PADA PT. PLN (PERSERO) APD SEMARANG) STRATEGI PENGEMBANGAN USAHA KERAJINAN ENCENG GONDOK SEBAGAI PRODUK UNGGULAN KABUPATEN SEMARANG MENGGUNAKAN ANALISIS RANTAI NILAI More cited articles
  1. Adisasmito, W., Amir, V., Atin, A., Megraini, A., & Kusuma, D. (2020). Geographic and socioeconomic disparity in cardiovascular risk factors in Indonesia: Analysis of the basic health research 2018. BMC Public Health, 20. https://doi.org/10.1186/s12889-020-09099-1
  2. Aligato, M. F., Endoma, V., Wachinger, J., Landicho-Guevarra, J., Bravo, T. A., Guevarra, J. R., Landicho, J., McMahon, S. A., & Reñosa, M. D. C. (2021). “Unfocused groups”: Lessons learnt amid remote focus groups in the Philippines. Family Medicine and Community Health, 9. https://doi.org/10.1136/fmch-2021-001098
  3. Alsa, A., Fuad, Z., Pranoto, E., & Ardika, N. (2022). JURIDICAL BOXING OF GOVERNMENT PROCUREMENT OF GOODS AND SERVICES xxx Juridical Boxing of Government Procurement of Goods and Services. In Journal of Engineering, Social and Health (Vol. 2, Issue 3). https://ajesh.ph/index.php/gp
  4. Anggriani, Y., Ramadaniati, H. U., Sarnianto, P., Pontoan, J., & Suryawati, S. (2020). The Impact of Pharmaceutical Policies on Medicine Procurement Pricing in Indonesia Under the Implementation of Indonesia’s Social Health Insurance System. Value in Health Regional Issues, 21, 1–8. https://doi.org/10.1016/j.vhri.2019.05.005
  5. Angius, A., Colledani, M., & Horvath, A. (2018). Lead-time-oriented production control policies in two machine production lines. IISE Transactions, 50(3), 178–190. https://doi.org/10.1080/24725854.2017.1417654
  6. Badshah, A., Ghani, A., Shamshirband, S., Aceto, G., & Pescapè, A. (2020). Performance-based service-level agreement in cloud computing to optimise penalties and revenue. IET Communications, 14(7), 1102–1112. https://doi.org/10.1049/iet-com.2019.0855
  7. Deng, Y., Zhang, X., Shen, H., He, Q., Wu, Z., Liao, W., & Yuan, M. (2020). Application of the Nano-Drug Delivery System in Treatment of Cardiovascular Diseases. In Frontiers in Bioengineering and Biotechnology (Vol. 7). Frontiers Media S.A. https://doi.org/10.3389/fbioe.2019.00489
  8. Dessy Angraini, Alfa Novitri, & Budi Irawan. (2025). Analisis Faktor Penyebab Stock Out Obat di Gudang Farmasi RSI Ibnu Sina Padang. SEHATMAS: Jurnal Ilmiah Kesehatan Masyarakat, 4(1), 307–321. https://doi.org/10.55123/sehatmas.v4i1.3453
  9. Fofana, F., Bazeley, P., & Regnault, A. (2020). Applying mixed methods design to test saturation for qualitative data in health outcomes research. PLoS ONE, 15(6). https://doi.org/10.1371/journal.pone.0234898
  10. Friska, E., Suryoputro, A., Kusumastuti, W., Kebijakan, A. D., Fakultas, K., Masyarakat, K., & Diponegoro, U. (2019). Analisis Proses Pengadaan Guna Menjamin Ketersediaan Obat di RSUD Tugurejo Semarang. In Juli
  11. Hinde, S., Harrison, A., Bojke, L., & Doherty, P. (2020). Quantifying the impact of delayed delivery of cardiac rehabilitation on patients’ health. European Journal of Preventive Cardiology, 27(16), 1775–1781. https://doi.org/10.1177/2047487320912625
  12. Khaerun Nisa, I., Yuliasih, N., Wuryandari, T., & Hidayati, N. R. (2023). Procurement Analysis of Pharmaceutical Supplies with Lean Hospital Approach in Pharmacy Department of Hospital “X” Tegal, Indonesia. International Journal of Multidisciplinary Research and Analysis, 06(04). https://doi.org/10.47191/ijmra/v6-i4-31
  13. Li, Y., Cao, G. Y., Jing, W. Z., Liu, J., & Liu, M. (2023). Global trends and regional differences in incidence and mortality of cardiovascular disease, 1990−2019: findings from 2019 global burden of disease study. European Journal of Preventive Cardiology, 30(3), 276–286. https://doi.org/10.1093/eurjpc/zwac285
  14. Lu, J., Long, H., Shen, Y., Wang, J., Geng, X., Yang, Y., Mao, Z., & Li, J. (2022). The change of drug utilization in China’s public healthcare institutions under the “4 + 7” centralized drug procurement policy: Evidence from a natural experiment in China. Frontiers in Pharmacology, 13. https://doi.org/10.3389/fphar.2022.923209
  15. Lušňáková, Z., Dicsérová, S., & Šajbidorová, M. (2021). Efficiency of managerial work and performance of managers: Time management point of view. Behavioral Sciences, 11(12). https://doi.org/10.3390/bs11120166
  16. Maria, R. A., Yanandra, A., & Putri, E. (2022). BULLET: Jurnal Multidisiplin Ilmu Faktor-Faktor Yang Mengakibatkan Tingginya Lead Time Pengiriman Obat Dari PBF Di Rumah Sakit Cahya Kawaluyan
  17. Muhia, J., Waithera, L., & Songole, R. (2017). Factors Affecting the Procurement of Pharmaceutical Drugs: A Case Study of Narok County Referral Hospital, Kenya. Medical & Clinical Reviews, 03(04). https://doi.org/10.21767/2471-299x.1000061
  18. Mwandotto, P. W., & Muli, S. (2023). Lead Time Management Strategies and Performance of Pharmaceutical Manufacturing Firms in Kenya. In International Journal of Supply Chain Management (Vol. 8, Issue 4). www.iprjb.org
  19. Mwangolo Chikophe, R., Mwaura Tenambergen, W., & Kawila Kyalo, C. (2024). Influence of Procurement Process on Availability of Essential Drugs in Public Health Facilities in Mombasa County. In International Journal of Health Sciences (Vol. 7, Issue 3). www.carijournal.org
  20. Mwita, K. (2022). Factors to consider when choosing data collection methods. International Journal of Research in Business and Social Science (2147- 4478), 11(5), 532–538. https://doi.org/10.20525/ijrbs.v11i5.1842
  21. Nardia, S. U., & Sjaaf, A. C. (2021). Policy Implementation Performance Related to the Procurement of PRB Drugs in the Subdistrict Primary Healthcare Center Pharmacy and PRB Pharmacy in Central Jakarta Quarter I, II, and III of 2019. Journal of Indonesian Health Policy and Administration, 6(1). https://doi.org/10.7454/ihpa.v6i1.4281
  22. Prasetyo Nugroho, M. Z., Nugroho, M. E., & Susanti, M. (2020). Study and Analysis of Delays in the Material Procurement Process: A case study of Steel Manufacturing Companies at Indonesia. International Journal of Engineering Research and Advanced Technology, 06(01), 01–08. https://doi.org/10.31695/ijerat.2020.3588
  23. Pujianto, H., Nasihardani, D., Wiyatno, T. N., Saputra, J. C., & Satrio, R. (2025). Analysis of Medicine Delays for Acute Respiratory Infections in Hospitals in the Jakarta Regional. Daerah Khusus Ibukota Jakarta, 17(1). https://doi.org/10.24853/jurtek.17.1.41-52
  24. Riera, R., Bagattini, A. M., Rafael, ;, Pacheco, L., Daniela, ;, Pachito, V., Roitberg, F., & Ilbawi, A. (2021). CANCER PREVENTION AND CONTROL review articles Delays and Disruptions in Cancer Health Care Due to COVID-19 Pandemic: Systematic Review. JCO Global Oncol, 7, 311–323. https://doi.org/10.1200/GO.20
  25. Solarino, A. M., & Aguinis, H. (2021). Challenges and Best-practice Recommendations for Designing and Conducting Interviews with Elite Informants. Journal of Management Studies, 58(3), 649–672. https://doi.org/10.1111/joms.12620

Last update:

No citation recorded.

Last update: 2025-05-21 12:43:41

No citation recorded.